GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Baolingbao Biology Co Ltd (SZSE:002286) » Definitions » Scaled Net Operating Assets

Baolingbao Biology Co (SZSE:002286) Scaled Net Operating Assets : 0.78 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Baolingbao Biology Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Baolingbao Biology Co's operating assets for the quarter that ended in Mar. 2024 was ¥2,416 Mil. Baolingbao Biology Co's operating liabilities for the quarter that ended in Mar. 2024 was ¥354 Mil. Baolingbao Biology Co's Total Assets for the quarter that ended in Dec. 2023 was ¥2,659 Mil. Therefore, Baolingbao Biology Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.78.


Baolingbao Biology Co Scaled Net Operating Assets Historical Data

The historical data trend for Baolingbao Biology Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baolingbao Biology Co Scaled Net Operating Assets Chart

Baolingbao Biology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 0.54 0.58 0.71 0.68

Baolingbao Biology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.74 0.72 0.74 0.78

Competitive Comparison of Baolingbao Biology Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Baolingbao Biology Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baolingbao Biology Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Baolingbao Biology Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Baolingbao Biology Co's Scaled Net Operating Assets falls into.



Baolingbao Biology Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Baolingbao Biology Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(2416.156-382.072)/3006.135
=0.68

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2658.892 - 242.736
=2416.156

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=675.407 - 38.145 - 255.19
=382.072

Baolingbao Biology Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(2415.853-354.135)/2658.892
=0.78

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2653.609 - 237.756
=2415.853

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=697.847 - 41.501 - 302.211
=354.135

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baolingbao Biology Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Baolingbao Biology Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Baolingbao Biology Co (SZSE:002286) Business Description

Traded in Other Exchanges
N/A
Address
NO.1,Dongwaihuan Road, Hi-Tech Development Zone, Yucheng, CHN
Baolingbao Biology Co Ltd is engaged in providing biotechnology products and services. The products of the company include oligosaccharide, carbohydrate, sugar alcohol, dietary fiber, starch series, and syrup series.
Executives
Zhang Guo Gang Directors, executives
Wang Qiang Directors, executives
Huang Yong Qiang Independent director
Jia Wei Chen Supervisors
Zhang Xin Rong Independent director
Liu Zong Li Directors, executives
Liu Feng Directors, executives
Li Xia Directors, executives
Wang Nai Qiang Supervisors
Xue Jian Ping Directors, executives
Yang Yuan Zhi Directors, executives

Baolingbao Biology Co (SZSE:002286) Headlines

No Headlines